Mutating for Profit
Pharmaceutical giant Pfizer executive admits in interview with Project Veritas that the company was mutating coronavirus so as to be ahead of competitors
A video from Project Veritas the independent media platform shows a Pfizer executive, Jordon Trishton Walker, claiming that his company is exploring a way to “mutate” the virus causing COVID-19 through “Directed Evolution.” The controversial video has garnered over 14 million views on Twitter in the first 24 hours of its upload.
“One of the things we [Pfizer] are exploring is like, why don’t we just mutate it [coronavirus] ourselves so we could create — preemptively develop new vaccines, right? So, we have to do that. If we’re gonna do that though, there’s a risk of like, as you could imagine — no one wants to be having a pharma company mutating f**king viruses,” Walker said.
“From what I’ve heard is they [Pfizer scientists] are optimising it [coronavirus mutation process], but they’re going slow because everyone is very cautious — obviously, they don’t want to accelerate it too much. I think they are also just trying to do it as an exploratory thing because you obviously don’t want to advertise that you are figuring out future mutations.” He continued.
At the meeting held in a restaurant at an undisclosed location the Pfizer executive pleaded for silence.
“Don’t tell anyone. Promise you won’t tell anyone. The way it [the experiment] would work is that we put the virus in monkeys, and we successively cause them to keep infecting each other, and we collect serial samples from them.”
He also alleged that the coronavirus was developed in Wuhan.
“You have to be very controlled to make sure that this virus [coronavirus] that you mutate doesn’t create something that just goes everywhere. Which, I suspect, is the way that the virus started in Wuhan, to be honest. It makes no sense that this virus popped out of nowhere. It’s bullsh*t,” Walker said.
Walker also admitted that the coronavirus could be used as a biological weapon and work was ongoing on more potent variants.
“You’re not supposed to do Gain-of-Function research with viruses. Regularly not. We can do these selected structure mutations to make them more potent. There is research ongoing about that. I don’t know how that is going to work. There better not be any more outbreaks because Jesus Christ,” he said.
He further explained that the pandemic has been a “cash cow” and will continue into the foreseeable future.
“Some of the time there are mutations that pop up that we are not prepared for. Like with Delta and Omicron. And things like that. Who knows? Either way, it’s going to be a cash cow. COVID is going to be a cash cow for us for a while going forward. Like obviously,” Walker said.
He also claimed that the pharmaceutical industry employs former government regulators when they retire in a “revolving door policy” which is bad for public health.
“Because if the regulators who review our drugs, you know that once they stop being a regulator, they want to go work for the company,” said Walker, “they are not going to be harsh on the company where they’re getting their job.”
Project Veritas was able to confirm that Walker was a director at Pfizer after obtaining internal documents.
“We’ve obtained internal Pfizer docs verifying Jordan Walker as Pfizer Director, Research & Development Strategic Operations Graduated Yale 2013 Doctor Med at U of Texas Southwestern medical school. His supervisor reports to Mikael Dolsten who reports to Albert Bourla, CEO.” James’ o Keefe of Project Veritas tweeted on Thursday.
This is not the first time Pfizer was embroiled in controversy.
1986: Pfizer had to withdraw an artificial heart valve from the market after defects led to it being implicated in over 300 deaths. The US Food and Drug Administration (FDA) withdrew its approval for the product in 1986 and Pfizer agreed to pay hundreds of millions of dollars in compensation after multiple lawsuits were brought against it.
2003: Pfizer has long been condemned for profiteering from AIDS drugs. In 2003 for example, it walked away from a licencing deal for its Rescriptor drug that would have made it cheaper for poorer countries.
2011: Pfizer was forced to pay compensation to families of children killed in the controversial Trovan drug trial. During the worst meningitis epidemic seen in Africa, in 1996, Pfizer ran a trial in Nigeria their new drug Trovan. Five of the 100 children who took Trovan died and it caused liver damage, while it caused lifelong disabilities in those who survived. But another group of 100 children were given the conventional “gold standard” meningitis antibiotic as a “control” group for comparison. Six of them also tragically died because, the families said, Pfizer had given them less than the recommended level of the conventional antibiotic in order to make Trovan look more effective.
2012: Pfizer had to pay around $1billion to settle lawsuits claiming its Prempro drug caused breast cancer. Prempro was used in hormone replacement therapy, usually for women going through the menopause. The settlements came after six years of trials and hardship for the women affected.
2013: Pfizer paid out $273 million to settle over 2,000 cases in the US that accused its smoking treatment drug Chantix of provoking suicidal and homicidal thoughts, self harm and severe psychological disorders. Pfizer was also accused of improperly excluding patients with a history of depression or other mental disturbances from trials for the drug. Later, in 2017, a coroner in Australia ruled that the drug had contributed to a man’s suicide. The man’s mother campaigned to change the label on the drug.
2020: Pfizer reached an agreement with thousands of customers of its depo-testosterone drug in 2018 after they sued it for increasing the likelihood of numerous issues, including heart attacks.
Project Veritas said more information will be released to the public in the coming days.
Source Project Veritas/Twitter/Corporate Watch